Since anti-MAG antibodies are found in more than 70% of patients with typical M component-related demyelinating polyneuropathy [4], in clinical practice, an anti-MAG antibody test is performed only in patients with detectable IgM monoclonal gammopathy. This evidence concerns the gene MAG and monoclonal gammopathy.